Mariner’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Mariner's RXRX Position: Q3 2026 in Review
Mariner opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 66,188 shares worth $273K. The stake represents ﹤0.01% of the portfolio and ranks #2895 among its holdings. This is a return to the name: Mariner previously reported a position in RXRX as recently as Q3 2025.
Mariner first reported a position in RXRX in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.12M in Q3 2022. 354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Mariner held 66,188 shares of Recursion Pharmaceuticals worth $273K as of Q3 2026.
- Recursion Pharmaceuticals was a new Mariner position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q3 2026, its #2895 holding.
- Mariner first reported a position in Recursion Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
- Mariner's Recursion Pharmaceuticals position peaked at $2.12M in Q3 2022.
- 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Mariner's 13F filing for Q3 2026, filed 12 Nov 2026.